These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
436 related articles for article (PubMed ID: 16386795)
1. Zinc(II) complexes with potent cyclin-dependent kinase inhibitors derived from 6-benzylaminopurine: synthesis, characterization, X-ray structures and biological activity. Trávnícek Z; Krystof V; Sipl M J Inorg Biochem; 2006 Feb; 100(2):214-25. PubMed ID: 16386795 [TBL] [Abstract][Full Text] [Related]
2. Mixed ligand complexes of platinum(II) and palladium(II) with cytokinin-derived compounds Bohemine and Olomoucine: X-ray structure of [Pt(BohH+-N7)Cl(3)].9/5H2O [Boh=6-(benzylamino)-2-[(3-(hydroxypropyl)-amino]-9-isopropylpurine, Bohemine]. Trávnícek Z; Malon M; Zatloukal M; Dolezal K; Strnad M; Marek J J Inorg Biochem; 2003 Apr; 94(4):307-16. PubMed ID: 12667701 [TBL] [Abstract][Full Text] [Related]
3. Synthesis, characterization and assessment of the cytotoxic properties of cis and trans-[Pd(L)(2)Cl(2)] complexes involving 6-benzylamino-9-isopropylpurine derivatives. Trávnícek Z; Szucová L; Popa I J Inorg Biochem; 2007 Mar; 101(3):477-92. PubMed ID: 17208304 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, spectral study and cytotoxicity of platinum(II) complexes with 2,9-disubstituted-6-benzylaminopurines. Malon M; Trávnícek Z; Marek R; Strnad M J Inorg Biochem; 2005 Nov; 99(11):2127-38. PubMed ID: 16143400 [TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo biological activity screening of Ru(III) complexes involving 6-benzylaminopurine derivatives with higher pro-apoptotic activity than NAMI-A. Trávníček Z; Matiková-Mal'arová M; Novotná R; Vančo J; Stěpánková K; Suchý P J Inorg Biochem; 2011 Jul; 105(7):937-48. PubMed ID: 21536006 [TBL] [Abstract][Full Text] [Related]
6. Preparation, physicochemical properties and biological activity of copper(II) complexes with 6-(2-chlorobenzylamino)purine (HL1) or 6-(3-chlorobenzylamino)purine (HL2). The single-crystal X-ray structure of. Trávnícek Z; Malon M; Sindelál Z; Dolezal K; Rolcík J; Krystof V; Strnad M; Marek J J Inorg Biochem; 2001 Mar; 84(1-2):23-32. PubMed ID: 11330478 [TBL] [Abstract][Full Text] [Related]
7. The first iron(III) complexes with cyclin-dependent kinase inhibitors: Magnetic, spectroscopic (IR, ES+ MS, NMR, (57)Fe Mössbauer), theoretical, and biological activity studies. Trávnícek Z; Popa I; Cajan M; Zboril R; Krystof V; Mikulík J J Inorg Biochem; 2010 Apr; 104(4):405-17. PubMed ID: 20056279 [TBL] [Abstract][Full Text] [Related]
8. Novel platinum(II) and palladium(II) complexes with cyclin-dependent kinase inhibitors: synthesis, characterization and antitumour activity. Szucová L; Trávnícek Z; Zatloukal M; Popa I Bioorg Med Chem; 2006 Jan; 14(2):479-91. PubMed ID: 16198575 [TBL] [Abstract][Full Text] [Related]
9. Zinc(II) complexes derived from pyridine-2-carbaldehyde thiosemicarbazone and (1E)-1-pyridin-2-ylethan-1-one thiosemicarbazone. Synthesis, crystal structures and antiproliferative activity of zinc(II) complexes. Kovala-Demertzi D; Yadav PN; Wiecek J; Skoulika S; Varadinova T; Demertzis MA J Inorg Biochem; 2006 Sep; 100(9):1558-67. PubMed ID: 16828164 [TBL] [Abstract][Full Text] [Related]
10. Roscovitine-based CDK inhibitors acting as N-donor ligands in the platinum(II) oxalato complexes: preparation, characterization and in vitro cytotoxicity. Trávnícek Z; Starha P; Popa I; Vrzal R; Dvorák Z Eur J Med Chem; 2010 Oct; 45(10):4609-14. PubMed ID: 20692737 [TBL] [Abstract][Full Text] [Related]
11. Synthesis, crystal structures, and biological evaluation of Cu(II) and Zn(II) complexes of 2-benzoylpyridine Schiff bases derived from S-methyl- and S-phenyldithiocarbazates. Li MX; Zhang LZ; Chen CL; Niu JY; Ji BS J Inorg Biochem; 2012 Jan; 106(1):117-25. PubMed ID: 22112848 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, structural characterization and influence on the phagocytic activity of human neutrophils of thiazoline and thiazine derivative ligands and their zinc(II) complexes. Barros-García FJ; Bernalte-García A; Lozano-Vila AM; Luna-Giles F; Pariente JA; Pedrero-Marín R; Rodríguez AB J Inorg Biochem; 2006 Nov; 100(11):1861-70. PubMed ID: 16963122 [TBL] [Abstract][Full Text] [Related]
13. Zinc(II), cadmium(II) and mercury(II) complexes of the vitamin B1 antagonist oxythiamine. Casas JS; Castellano EE; Couce MD; Ellena J; Sánchez A; Sordo J; Taboada C J Inorg Biochem; 2006 Jan; 100(1):124-32. PubMed ID: 16337684 [TBL] [Abstract][Full Text] [Related]
14. Cytotoxic activity, X-ray crystal structures and spectroscopic characterization of cobalt(II), copper(II) and zinc(II) coordination compounds with 2-substituted benzimidazoles. Sánchez-Guadarrama O; López-Sandoval H; Sánchez-Bartéz F; Gracia-Mora I; Höpfl H; Barba-Behrens N J Inorg Biochem; 2009 Sep; 103(9):1204-13. PubMed ID: 19628280 [TBL] [Abstract][Full Text] [Related]
15. Crystal structures, spectroscopic properties of new cobalt(II), nickel(II), zinc(II) and palladium(II) complexes derived from 2-acetyl-5-chloro thiophene thiosemicarbazone: Anticancer evaluation. Şen B; Kalhan HK; Demir V; Güler EE; Kayalı HA; Subaşı E Mater Sci Eng C Mater Biol Appl; 2019 May; 98():550-559. PubMed ID: 30813058 [TBL] [Abstract][Full Text] [Related]
16. Synthetic, spectral, magnetic and in vitro cytotoxic activity studies of cobalt(II) complexes with cytokinin derivatives: X-ray structure of 6-(3-methoxybenzylamino)purinium chloride monohydrate. Trávnícek Z; Klanicová A; Popa I; Rolcík J J Inorg Biochem; 2005 Mar; 99(3):776-86. PubMed ID: 15708799 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of cyclin-dependent kinases by purine analogues: crystal structure of human cdk2 complexed with roscovitine. De Azevedo WF; Leclerc S; Meijer L; Havlicek L; Strnad M; Kim SH Eur J Biochem; 1997 Jan; 243(1-2):518-26. PubMed ID: 9030780 [TBL] [Abstract][Full Text] [Related]
18. Synthesis, structural characterization and antimicrobial activities of 12 zinc(II) complexes with four thiosemicarbazone and two semicarbazone ligands. Kasuga NC; Sekino K; Ishikawa M; Honda A; Yokoyama M; Nakano S; Shimada N; Koumo C; Nomiya K J Inorg Biochem; 2003 Aug; 96(2-3):298-310. PubMed ID: 12888265 [TBL] [Abstract][Full Text] [Related]
19. In vivo metabolism of 2,6,9-trisubstituted purine-derived cyclin-dependent kinase inhibitor bohemine in mice: glucosidation as the principal metabolic route. Chmela Z; Veselý J; Lemr K; Rypka M; Hanus J; Havlícek L; Krystof V; Michnová L; Fuksová K; Lukes J Drug Metab Dispos; 2001 Mar; 29(3):326-34. PubMed ID: 11181503 [TBL] [Abstract][Full Text] [Related]
20. Solid-state and solution-state coordination chemistry of the zinc triad with the mixed N,S donor ligand bis(2-methylpyridyl) sulfide. Berry SM; Bebout DC; Butcher RJ Inorg Chem; 2005 Jan; 44(1):27-39. PubMed ID: 15627357 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]